Your browser doesn't support javascript.
loading
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss.
Zahoor, Muhammad; Westhrin, Marita; Aass, Kristin Roseth; Moen, Siv Helen; Misund, Kristine; Psonka-Antonczyk, Katarzyna Maria; Giliberto, Mariaserena; Buene, Glenn; Sundan, Anders; Waage, Anders; Sponaas, Anne-Marit; Standal, Therese.
Afiliação
  • Zahoor M; Centre of Molecular Inflammation Research and.
  • Westhrin M; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Aass KR; Centre of Molecular Inflammation Research and.
  • Moen SH; Department of Hematology, St. Olavs Hospital, Trondheim, Norway; and.
  • Misund K; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Psonka-Antonczyk KM; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Giliberto M; Biophysics and Medical Technology, Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway.
  • Buene G; Centre of Molecular Inflammation Research and.
  • Sundan A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Waage A; Centre of Molecular Inflammation Research and.
  • Sponaas AM; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Standal T; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Blood Adv ; 1(27): 2656-2666, 2017 Dec 26.
Article em En | MEDLINE | ID: mdl-29296919

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos